$581M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | TNGX Tango Therapeutics Inc | 1.2M | +508.7% | $38M | 6.6% |
| 2 | ABIVAX SA Abivax Sa | 283,657 | −9.6% | $38M | 6.5% |
| 3 | RVMD Revolution Medicines Inc | 159,943 | −43.2% | $30M | 5.2% |
| 4 | ERAS Erasca Inc | 1.6M | +552.8% | $29M | 4.9% |
| 5 | TYRA Tyra Biosciences Inc | 632,754 | +227.6% | $20M | 3.5% |
| 6 | DNTH Dianthus Therapeutics Inc | 200,851 | +134.9% | $20M | 3.4% |
| 7 | ELVN Enliven Therapeutics Inc | 346,914 | −4.5% | $18M | 3.0% |
| 8 | MLYS Mineralys Therapeutics Inc | 602,686 | +13.0% | $16M | 2.8% |
| 9 | BHVN Biohaven Ltd | 1.1M | −33.3% | $16M | 2.7% |
| 10 | SRZN Surrozen Inc | 602,798 | +14.7% | $14M | 2.4% |
| 11 | KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl | 209,234 | — | $13M | 2.3% |
| 12 | SRRK Scholar Rock Hldg Corp | 239,146 | −76.9% | $13M | 2.3% |
| 13 | ALKS Alkermes Plc | 248,015 | +208.1% | $13M | 2.2% |
| 14 | TRAX First Tracks Biotherapeutics | 622,723 | — | $13M | 2.2% |
| 15 | PRAX Praxis Precision Medicines I | 37,243 | −33.8% | $12M | 2.1% |
| 16 | ROIV Roivant Sciences Ltd | 348,408 | −9.7% | $12M | 2.1% |
| 17 | BIOA Bioage Labs Inc | 464,171 | +37.1% | $11M | 2.0% |
| 18 | CGON Cg Oncology Inc | 159,349 | −22.5% | $11M | 2.0% |
| 19 | ORKA Oruka Therapeutics Inc | 116,461 | — | $11M | 1.9% |
| 20 | IMVT Immunovant Inc | 276,527 | −63.0% | $11M | 1.8% |
| 21 | CELC Celcuity Inc | 98,203 | +63.5% | $10M | 1.8% |
| 22 | RLMD Relmada Therapeutics Inc | 1.5M | +144.4% | $10M | 1.7% |
| 23 | CLYM Climb Bio Inc | 742,745 | — | $10M | 1.7% |
| 24 | SYRE Spyre Therapeutics Inc | 106,926 | −36.2% | $9M | 1.6% |
| 25 | ZURA Zura Bio Ltd | 1.4M | +81.6% | $8M | 1.4% |
| 26 | INFLARX NV Inflarx Nv | 3.2M | — | $7M | 1.2% |
| 27 | AMLX Amylyx Pharmaceuticals Inc | 384,304 | −42.6% | $7M | 1.2% |
| 28 | CLDX Celldex Therapeutics Inc New | 178,412 | −29.8% | $7M | 1.1% |
| 29 | OVID Ovid Therapeutics Inc | 2.4M | — | $7M | 1.1% |
| 30 | EQ Equillium Inc | 2.0M | — | $6M | 1.1% |
| 31 | DFTX Definium Therapeutics Inc | 137,124 | −57.9% | $6M | 1.1% |
| 32 | CYTK Cytokinetics Inc | 75,603 | −41.7% | $6M | 1.1% |
| 33 | DMRA Damora Therapeutics Inc | 216,194 | — | $6M | 1.0% |
| 34 | IVA Inventiva Sa | 1.4M | — | $5M | 0.9% |
| 35 | IPSC Century Therapeutics Inc | 2.1M | — | $5M | 0.9% |
| 36 | AURA Aura Biosciences Inc | 714,280 | — | $5M | 0.9% |
| 37 | EYPT Eyepoint Inc | 338,471 | −58.3% | $5M | 0.8% |
| 38 | ASMB Assembly Biosciences Inc | 170,378 | −8.1% | $5M | 0.8% |
| 39 | WHWK Whitehawk Therapeutics Inc | 1.0M | +8.7% | $5M | 0.8% |
| 40 | XENE Xenon Pharmaceuticals Inc | 76,075 | −46.0% | $5M | 0.8% |
| 41 | UNIQURE NV Uniqure Nv | 88,115 | +12.9% | $4M | 0.7% |
| 42 | CMPS Compass Pathways Plc | 284,769 | — | $4M | 0.7% |
| 43 | AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc | 118,000 | — | $4M | 0.7% |
| 44 | MPLT Maplight Therapeutics Inc | 106,906 | +6.9% | $4M | 0.7% |
| 45 | ALMS Alumis Inc | 135,736 | −40.9% | $4M | 0.7% |
| 46 | AXSM Axsome Therapeutics Inc. | 15,375 | — | $4M | 0.6% |
| 47 | GLUE Monte Rosa Therapeutics Inc | 153,544 | — | $4M | 0.6% |
| 48 | ACAD Acadia Pharmaceuticals Inc | 143,167 | −41.0% | $4M | 0.6% |
| 49 | SLDB Solid Biosciences Inc | 358,780 | +83.6% | $4M | 0.6% |
| 50 | PSNL Personalis Inc | 247,783 | — | $3M | 0.6% |